Showing 1931-1940 of 8649 results for "".
- Topcon Healthcare Launches IDHea to Fuel AI and Digital Health Innovation from the Eyehttps://modernod.com/news/topcon-healthcare-launches-idhea-to-fuel-ai-and-digital-health-innovation-from-the-eye/2482792/Topcon Healthcare announced the launch of the Institute of Digital Health (IDHea), an ocular data-as-a-service platform designed to accelerate AI research and digital health innovation. IDHea is designed to provide fast and secure access to unique real-world and clinical trial datasets,
- FDA Expands Luminopia's Label to Include Patients 8 to 12 with Amblyopiahttps://modernod.com/news/fda-expands-luminopias-label-to-include-patients-8-to-12-with-amblyopia/2482768/Luminopia announced that the FDA has cleared its amblyopia treatment for patients aged 8 to 12 years, expanding its existing label from patients 4 to 7 years old with amblyopia associated with anisometropia and/or mild strabismus. The expanded label opens the door to a new treatment opt
- Alcon Launches UNITY VCS and UNITY CS for for Vitreoretinal and Cataract Surgeryhttps://modernod.com/news/alcon-launches-unity-vcs-and-unity-cs-for-for-vitreoretinal-and-cataract-surgery/2482763/Alcon announced the launch of the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS). The platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). It is designed to deliver superior efficiency for vit
- Nordic Pharma Launches Authorized Generic of Maxitrolhttps://modernod.com/news/nordic-pharma-launches-authorized-generic-of-maxitrol/2482759/Nordic Pharma announced a partnership with Harrow to launch an authorized generic of Maxitrol (Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic suspension), for the treatment and relief of bacterial eye infections. Maxitrol and generic equivalents had a
- Nordic Pharma Presents Data and Patient Experience Study for Lacrifill Canalicular Gel at ASCRShttps://modernod.com/news/nordic-pharma-presents-data-and-patient-experience-study-for-lacrifill-canalicular-gel-at-ascrs/2482756/Nordic Pharma will be presenting recently published patient data and patient experience study for Lacrifill Canalicular Gel, a novel therapy for dry eye symptoms, during the ASCRS annual meeting in Los Angeles. The April issue of Ca
- Sight Sciences Launches OMNI Edge Surgical System at ASCRShttps://modernod.com/news/sight-sciences-to-debut-omni-edge-surgical-system-at-ascrs/2482748/Sight Sciences announced the expansion of the OMNI product family by launching the OMNI Edge Surgical System. The new technology will debut at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, taking place April 25–27 in Los Angeles.<
- Nordic Pharma Receieves CE Mark Approval for Lacrifill Canalicular Gelhttps://modernod.com/news/nordic-pharma-receieves-ce-mark-approval-for-lacrifill-canalicular-gel/2482729/Nordic Group, the parent company of Nordic Pharma, announced that its dry eye therapy Lacrifill has received CE mark approval. This regulatory milestone, which Nordic says was achieved several months ahead of schedule, allows Nordic Pharma to introduce Lacrifill across Europea
- Hoya Launches VisuPro Advanced Focus Spectacle Lenses for Patients Experiencing Early Symptoms of Presbyopiahttps://modernod.com/news/hoya-launches-visupro-advanced-focus-spectacle-lenses-for-patients-experiencing-first-symptoms-of-presbyopia/2482724/Hoya has launched its VisuPro All Day and VisuPro Flex advanced focus spectacle lenses, which are designed to help people in their late 30s to mid-40s that are beginning to experience presbyopia. As people enter this age group, they may begi
- Alcon Boosts Femtosecond Laser Portfolio with Acquisition of Lensarhttps://modernod.com/news/alcon-boosts-femtosecond-laser-technology-with-acquisition-of-lensar/2482713/Alcon and Lensar have entered into a definitive merger agreement through which Alcon intends to acquire Lensar for about $356 million. The acquisition includes ALLY Robotic Cataract Laser Treatment System, Lensar’s proprietary Streamline software technology, and Lensar
- Bausch + Lomb Launches Arise Orthokeratology Lens System in the UShttps://modernod.com/news/bausch-lomb-announces-arisetm-orthokeratology-lens-system-in-the-united-states/2482702/Bausch + Lomb announced the US launch of Arise, a lens fitting system designed to use intelligent, cloud-based technology to streamline the orthokeratology lens design process. Orthokeratology is a non-surgical method of vision correction that uses rigid, gas-permea